EUVIMEDEUVIMED entdecken
Crossref

Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII

Vadakattu Manasa, Shaik Mahammad Ghouse, Niccolò Paoletti, Kareena Sinha, Srikanth Danaboina, Nitesh Tamang iD, Devandla Soujanya, Venkata Madhavi Yaddanapudi, Claudiu T Supuran iD, Srinivas Nanduri iD

ChemMedChem · 25.02.2026 · 21 (4)

DOI: 10.1002/cmdc.202500959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 25.02.2026. Verfasst von Vadakattu Manasa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human carbonic anhydrases (hCAs), particularly the cancer‐linked isoforms hCA IX and XII, are essential in regulating the abnormal metabolism and pH gradient in cancer cells, facilitating tumor progression, invasiveness, and resistance to chemotherapy. In this study, we designed and synthesized twenty novel 6‐functionalized coumarin derivatives bearing 1,2,3‐triazole moieties via amide linkers of varying alkyl chain lengths. These molecules were screened for inhibitory effects on hCA isoforms I, II, IX, and XII. The data demonstrated selective inhibition to the cancer‐related isoforms hCA IX and XII ( K i values ranging from 79 to 96 nM), with negligible activity against the off‐target isoforms hCA I and II ( K i > 100 µM). Among the synthesized compounds, 6d , 7d, and 6f showed the highest potency of K i 79.5, 81.8, and 94.4 nM against hCA IX and 83.5, 88.3, and 79.5 nM against hCA XII, respectively. Structure–activity relationship analysis highlighted that shorter linkers and electron‐withdrawing substituents enhanced potency. Our study confirms the promise of the coumarin‐triazole scaffold as a selective and reliable platform for developing anticancer CA inhibitors.

Schlagwörter

Stichwörter der Autor:innen

1,2,3‐Triazolecarbonic anhydrasecoumarinpH gradienttumors

Autor:innen und Institutionen

  • Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India.
  • Sezione di Scienze Farmaceutiche e Nutraceutiche, Neurofarba Department, Università degli Studi di Firenze, Sesto Fiorentino, Florence, Italy.

ORCID-Profile: Nitesh Tamang, Claudiu T Supuran, Srinivas Nanduri

Zitieren

APA

Manasa, V., Ghouse, S. M., Paoletti, N., Sinha, K., Danaboina, S., Tamang, N., Soujanya, D., Yaddanapudi, V. M., Supuran, C. T., & Nanduri, S. (2026). Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII. ChemMedChem, 21(4). https://doi.org/10.1002/cmdc.202500959

Vancouver

Manasa V, Ghouse SM, Paoletti N, Sinha K, Danaboina S, Tamang N, et al. Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII. ChemMedChem. 2026;21(4). doi:10.1002/cmdc.202500959

BibTeX
@article{Manasa2026,
  author = {Manasa, Vadakattu and Ghouse, Shaik Mahammad and Paoletti, Niccolò and Sinha, Kareena and Danaboina, Srikanth and Tamang, Nitesh and Soujanya, Devandla and Yaddanapudi, Venkata Madhavi and Supuran, Claudiu T and Nanduri, Srinivas},
  title = {Exploring Coumarin‐Triazole Derivatives as Selective Inhibitors of Carbonic Anhydrase IX and XII},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {4},
  doi = {10.1002/cmdc.202500959}
}
Kostenlos starten →